Jane Street’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-132,909
Closed -$17.5M 11552
2025
Q1
$17.5M Sell
132,909
-134,193
-50% -$16.7M 0.03% 1409
2024
Q4
$22.3M Sell
267,102
-27,758
-9% -$2.28M 0.04% 1184
2024
Q3
$21.6M Sell
294,860
-186,345
-39% -$14M 0.03% 1189
2024
Q2
$33M Buy
481,205
+428,607
+815% +$29.7M 0.04% 922
2024
Q1
$3.64M Sell
52,598
-114,318
-68% -$7.86M ﹤0.01% 3105
2023
Q4
$12M Buy
166,916
+148,015
+783% +$8.51M 0.01% 1763
2023
Q3
$985K Sell
18,901
-139,850
-88% -$8.15M ﹤0.01% 5203
2023
Q2
$10.1M Buy
158,751
+51,112
+47% +$3.18M 0.01% 1893
2023
Q1
$5.83M Buy
107,639
+34,913
+48% +$1.69M 0.01% 2235
2022
Q4
$3.85M Sell
72,726
-21,754
-23% -$1.09M 0.01% 2846
2022
Q3
$4.4M Buy
94,480
+67,729
+253% +$3.54M 0.01% 2808
2022
Q2
$1.53M Sell
26,751
-5,399
-17% -$306K ﹤0.01% 4672
2022
Q1
$1.97M Sell
32,150
-8,315
-21% -$432K ﹤0.01% 4789
2021
Q4
$2.12M Buy
40,465
+23,732
+142% +$997K ﹤0.01% 4374
2021
Q3
$624K Buy
16,733
+11,176
+201% +$389K ﹤0.01% 6859
2021
Q2
$227K Sell
5,557
-6,433
-54% -$238K ﹤0.01% 8629
2021
Q1
$407K Sell
11,990
-68,563
-85% -$2.38M ﹤0.01% 7170
2020
Q4
$2.56M Buy
80,553
+11,496
+17% +$302K 0.01% 3083
2020
Q3
$1.77M Sell
69,057
-159,174
-70% -$3.63M 0.01% 3228
2020
Q2
$5.86M Buy
228,231
+212,720
+1,371% +$4.31M 0.02% 1673
2020
Q1
$239K Sell
15,511
-314
-2% -$6.82K ﹤0.01% 4469
2019
Q4
$543K Buy
+15,825
New +$190K ﹤0.01% 3599
2017
Q4
Sell
-39,780
Closed -$628K 5366
2017
Q3
$628K Buy
+39,780
New +$584K 0.01% 2818
2017
Q2
Sell
-23,076
Closed -$375K 5061
2017
Q1
$375K Buy
23,076
+10,609
+85% +$154K ﹤0.01% 3195
2016
Q4
$188K Buy
+12,467
New +$176K ﹤0.01% 3756
2016
Q1
Sell
-4,946
Closed -$266K 4847
2015
Q4
$266K Sell
4,946
-12,671
-72% -$639K ﹤0.01% 3255
2015
Q3
$705K Buy
+17,617
New +$575K 0.01% 1945
2014
Q3
Sell
-11,000
Closed -$185K 3208
2014
Q2
$185K Buy
+11,000
New +$182K ﹤0.01% 2236

Other funds holding ITCI